Temocillin use in intensive care units: A Pharmacokinetic study of 6g per day in conventional administration vs. continuous infusion

Trial Profile

Temocillin use in intensive care units: A Pharmacokinetic study of 6g per day in conventional administration vs. continuous infusion

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Nov 2015

At a glance

  • Drugs Temocillin (Primary)
  • Indications Bacterial infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 16 Nov 2015 Status changed from recruiting to completed.
    • 16 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top